These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil. Costa JM, Segurado AC. J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090 [Abstract] [Full Text] [Related]
4. Prevalence of human T-cell leukemia virus types I and II in Switzerland. Böni J, Bisset LR, Burckhardt JJ, Joller-Jemelka HI, Bürgisser P, Perrin L, Gorgievski M, Erb P, Fierz W, Piffaretti JC, Schüpbach J, Swiss HIV Cohort Study. J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678 [Abstract] [Full Text] [Related]
6. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province]. Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172 [Abstract] [Full Text] [Related]
7. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses. Pancake BA, Zucker-Franklin D, Marmor M, Legler PM. Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367 [Abstract] [Full Text] [Related]
10. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D, HTLV Outcomes Study Investigators. J Infect Dis; 2004 Aug 01; 190(3):504-10. PubMed ID: 15243924 [Abstract] [Full Text] [Related]
11. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction]. Rolo Gómez F, De Armas MB, Mato Luis J, Lubián Caballero AL, Díaz Torres H. Rev Cubana Med Trop; 1997 Aug 01; 49(3):204-8. PubMed ID: 9685988 [Abstract] [Full Text] [Related]
12. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013. San Martín H, Balanda M, Vergara N, Valenzuela MA, Cartier L, Ayala S, Ramírez E. J Med Virol; 2016 Jun 01; 88(6):1067-75. PubMed ID: 26538335 [Abstract] [Full Text] [Related]
13. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H, Musharrafieh U, Ramia S, Almawi WY, Al-Jisr T, Ayoub T, Nabulsi-Majzoub M, Kazma H, Baz EK. Am J Infect Control; 2004 Jun 01; 32(4):220-3. PubMed ID: 15175617 [Abstract] [Full Text] [Related]
17. Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved. Eirin ME, Berini CA, Jones LR, Dilernia DA, Puca AA, Biglione MM. J Med Virol; 2010 Dec 01; 82(12):2116-22. PubMed ID: 20981802 [Abstract] [Full Text] [Related]